ANXNF logo

Annexin Pharmaceuticals AB

ANXNF

$0.00

Key details

CEO

Jamal El-Mosleh

Employees

N/A

Headquarters

-

Sector

Health Technology

Industry

Pharmaceuticals: Major

About Annexin Pharmaceuticals AB

Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale production of Annexin A5. The company was founded by Anna Frostegård in 2014 and is headquartered in Stockholm, Sweden.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG